View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400, Bladder Cancer, Second Line
Protocol-ID: 1263 V1.0 (Mini), PEMB400, Bladder Ca, Second LineIndication(s)
- Bladder Cancer; ICD-10 C67.-
Links
- Pembrolizumab (keytruda) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 05.06.2019